Effects of 25-hydroxyvitamin D3 and 1,25-dihydroxyvitamin D 3 on cytokine production by human decidual cells

Biology of Reproduction

Volumn 75, Issue 6, 2006, Pages 816-822

  Evans, Katie N ^a   Nguyen, Lisa ^b   Chan, Junny ^c   Innes, Barbara A ^d   Bulmer, Judith N ^d   Kilby, Mark D ^c   Hewison, Martin ^a,b  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^b BURNS AND ALLEN RESEARCH INSTITUTE   (United States)

^c BIRMINGHAM WOMEN S HOSPITAL   (United Kingdom)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

Author keywords

1 hydroxylase; Cytokines; Decidua; Natural killer cell; Placenta; Pregnancy; Steroid hormones; Vitamin D

Indexed keywords

CALCIFEDIOL; CALCITRIOL; CATHELICIDIN; CD56 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR 2; INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 6; MESSENGER RNA; OXYGENASE; POLYPEPTIDE ANTIBIOTIC AGENT; SECOSTEROID; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VITAMIN D;

ARTICLE; AUTOCRINE EFFECT; CELL FUNCTION; CELL ISOLATION; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DECIDUA; DOWN REGULATION; EMBRYO; ENZYME ACTIVITY; ENZYME MECHANISM; FIRST TRIMESTER PREGNANCY; GENE EXPRESSION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNE RESPONSE; IMMUNOMODULATION; IMMUNOREGULATION; NATURAL KILLER CELL; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STROMA; THIRD TRIMESTER PREGNANCY; UPREGULATION; UTERUS; VITAMIN D METABOLISM;

25-HYDROXYVITAMIN D3 1-ALPHA-HYDROXYLASE; CALCIFEDIOL; CALCITRIOL; CELLS, CULTURED; CYTOKINES; DECIDUA; EMBRYO IMPLANTATION; FEMALE; HUMANS; KILLER CELLS, NATURAL; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, THIRD; RECEPTORS, CALCITRIOL; STEROID HYDROXYLASES; VITAMINS;

EID: 33751562279     PISSN: 00063363     EISSN: None     Source Type: Journal    
DOI: 10.1095/biolreprod.106.054056     Document Type: Article

References (57)

1. Lin R, White JH. The pleiotropic actions of vitamin D. Bioessays 2004; 26:21-28.
2. Bouillon R, Verstuyf A, Verlinden L, Eelen G, Mathieu C. Prospects for vitamin D receptor modulators as candidate drugs for cancer and (auto)immune diseases. Recent Results Cancer Res 2003; 164:353-356.
3. Jones G, Strugnell SA, DeLuca HF. Current understanding of the molecular actions of vitamin D. Physiol Rev 1998; 78:1193-1231.
4. Mathieu C, van Etten E, Decallonne B, Guilietti A, Gysemans C, Bouillon R, Overbergh L. Vitamin D and 1,25-dihydroxyvitamin D3 as modulators in the immune system. J Steroid Biochem Mol Biol 2004;89-90:449-452.
5. Deluca HF, Cantoma MT. Vitamin D: its role and uses in immunology. Faseb J 2001; 15:2579-2585.
6. Liu PT, Stenger S, Li H, Wenzel L, Tan BH, Krutzik SR, Ochoa MT, Schauber J, Wu K, Meinken C, Kamen DL, Wagner M, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science 2006; 311:1770-1773.
7. Rook GA, Steele J, Fraher L, Barker S, Karmali R, O'Riordan J, Stanford J. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes. Immunology 1986; 57:159-163.
8. 3. Cell Immunol 1989; 118:328-336.
9. Griffin MD, Lutz W, Phan VA, Bachman LA, McKean DJ, Kumar R. Dendritic cell modulation by 1α,25 dihydroxyvitamin D3 and its analogs: a vitamin D receptor-dependent pathway that promotes a persistent state of immaturity in vitro and in vivo. Proc Natl Acad Sci U S A 2001; 98:6800-6805.
10. 3 inhibits dendritic cell differentiation and maturation in vitro. Exp Hematol 2000; 28:575-583.
11. Piemonti L, Monti P, Sironi M, Fraticelli P, Leone BE, Dal Cin E, Allavena P, Di Carlo V. Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells. J Immunol 2000; 164:4443-4451.
12. Penna G, Adorini L. 1α,25-Dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation. J Immunol 2000; 164:2405-2411.
13. 3. Immunology 1986; 59:479-484.
14. 3 has a direct effect on naive CD4(+) T cells to enhance the development of Th2 cells. J Immunol 2001; 167:4974-4980.
15. Barrat FJ, Cua DJ, Boonstra A, Richards DF, Crain C, Savelkoul HF, de Waal-Malefyt R, Coffman RL, Hawrylowicz CM, O'Garra A. In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J Exp Med 2002; 195:603-616.
16. Griffin MD, Xing N, Kumar R. Vitamin D and its analogs as regulators of immune activation and antigen presentation. Annu Rev Nutr 2003; 23:117-145.
17. 3 as pluripotent immunomodulators. J Cell Biochem 2003; 88:223-226.
18. 3 by human dendritic cells. Blood 2003; 102:3314-3316.
19. Hewison M, Freeman L, Hughes SV, Evans KN, Bland R, Eliopoulos AG, Kilby MD, Moss PA, Chakraverty R. Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells. J Immunol 2003; 170:5382-5390.
20. 3 receptor expression are developmentally regulated during differentiation of human monocytes into macrophages. Blood 1993; 82:1300-1307.
21. 3, and the immune system. Am J Clin Nutr 2004; 80:1717S-1720S.
22. Hewison M, Zehnder D, Chakraverty R, Adams JS. Vitamin D and barrier function: a novel role for extra-renal 1α-hydroxylase. Mol Cell Endocrinol 2004; 215:31-38.
23. Hewison M, Gacad MA, Lemire J, Adams JS. Vitamin D as a cytokine and hematopoetic factor. Rev Endocr Metab Disord 2001; 2:217-227.
24. Bulmer JN, Pace D, Ritson A. Immunoregulatory cells in human decidua: morphology, immunohistochemistry and function. Reprod Nutr Dev 1988; 28:1599-1613.
25. Bulmer JN. Human endometrial lymphocytes in normal pregnancy and pregnancy loss. Ann N Y Acad Sci 1994; 734:185-192.
26. Trundley A, Moffett A. Human uterine leukocytes and pregnancy. Tissue Antigens 2004; 63:1-12.
27. Huddleston H, Schust DJ. Immune interactions at the maternal-fetal interface: a focus on antigen presentation. Am J Reprod Immunol 2004; 51:283-289.
28. Dosiou C, Giudice LC. Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 2005; 26:44-62.
29. Bulmer JN, Lash GE. Human uterine natural killer cells: a reappraisal. Mol Immunol 2005; 42:511-521.
30. 3 on in vitro lymphocyte reactions: arguments for a role at the matemofetal interface. Gynecol Obstet Invest 1991; 32:134-138.
31. 3 in vitro synthesis by human decidua and placenta. Nature 1979; 281:317-319.
32. 3 in pregnancy. Science 1979; 204:1311-1313.
33. 3 1α-hydroxylase expression in human placenta and decidua. Am J Pathol 2002; 161:105-114.
34. Evans KN, Bulmer JN, Kilby MD, Hewison M. Vitamin D and placental-decidual function. J Soc Gynecol Investig 2004; 11:263-271.
35. Imai K, Maeda M, Fujiwara H, Okamoto N, Kariya M, Emi N, Takakura K, Kanzaki H, Mori T. Human endometrial stromal cells and decidual cells express cluster of differentiation (CD) 13 antigen/aminopeptidase N and CD10 antigen/neutral endopeptidase. Biol Reprod 1992; 46:328-334.
36. Toki T, Shimizu M, Takagi Y, Ashida T, Konishi I. CD10 is a marker for normal and neoplastic endometrial stromal cells. Int J Gynecol Pathol 2002; 21:41-47.
37. Jones RK, Bulmer JN, Searle RF. Cytotoxic activity of endometrial granulated lymphocytes during the menstrual cycle in humans. Biol Reprod 1997; 57:1217-1222.
38. Bland R, Zehnder D, Hughes SV, Ronco PM, Stewart PM, Hewison M. Regulation of vitamin D-1α-hydroxylase in a human cortical collecting duct cell line. Kidney Int 2001; 60:1277-1286.
39. Brett R, Searle RF, Bulmer JN. Up-regulation of natural killer cell cytotoxicity by interleukin-2: the effect of sex and parity. Am J Reprod Immunol 1999; 41:356-359.
40. Honig A, Rieger L, Kapp M, Sutterlin M, Dietl J, Kammerer U. Indoleamine 2,3-dioxygenase (IDO) expression in invasive extravillous trophoblast supports role of the enzyme for materno-fetal tolerance. J Reprod Immunol 2004; 61:79-86.
41. Kovacs CS, Kronenberg HM. Matemal-fetal calcium and bone metabolism during pregnancy, puerperium, and lactation. Endocr Rev 1997; 18:832-872.
42. Yoshizawa T, Handa Y, Uematsu Y, Takeda S, Sekine K, Yoshihara Y, Kawakami T, Arioka K, Sato H, Uchiyama Y, Masushige S, Fukamizu A, et al. Mice lacking the vitamin D receptor exhibit impaired bone formation, uterine hypoplasia and growth retardation after weaning. Nat Genet 1997; 16:391-396.
43. Panda DK, Miao D, Tremblay ML, Sirois J, Farookhi R, Hendy GN, Goltzman D. Targeted ablation of the 25-hydroxyvitamin D 1α-hydroxylase enzyme: evidence for skeletal, reproductive, and immune dysfunction. Proc Natl Acad Sci U S A 2001; 98:7498-7503.
44. Anderson KV. Toll signaling pathways in the innate immune response. Curr Opin Immunol 2000; 12:13-19.
45. Hirata T, Osuga Y, Hirota Y, Koga K, Yoshino O, Harada M, Morimoto C, Yano T, Nishii O, Tsutsumi O, Taketani Y. Evidence for the presence of Toll-like receptor 4 system in the human endometrium. J Clin Endocrinol Metab 2005; 90:548-556.
46. Wang H, Hirsch E. Bacterially-induced preterm labor and regulation of prostaglandin-metabolizing enzyme expression in mice: the role of Toll-like receptor 4. Biol Reprod 2003; 69:1957-1963.
47. 3 production by cultured alveolar macrophages from normal human donors and from patients with pulmonary sarcoidosis. J Clin Endocrinol Metab 1987; 65:1201-1209.
48. 3 by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. J Am Soc Nephrol 2002; 13:621-629.
49. Ferry BL, Starkey PM, Sargent IL, Watt GM, Jackson M, Redman CW. Cell populations in the human early pregnancy decidua: natural killer activity and response to interleukin-2 of CD56-positive large granular lymphocytes. Immunology 1990; 70:446-452.
50. Sconocchia G, Keyvanfar K, El Ouriaghli F, Grube M, Rezvani K, Fujiwara H, McCoy JP Jr, Hensel N, Barrett AJ. Phenotype and function of a CD56+ peripheral blood monocyte. Leukemia 2005; 19:69-76.
51. Cooper MA, Fehniger TA, Caligiuri MA. The biology of human natural killer-cell subsets. Trends Immunol 2001; 22:633-640.
52. Jokhi PP, King A, Sharkey AM, Smith SK, Loke YW. Screening for cytokine messenger ribonucleic acids in purified human decidual lymphocyte populations by the reverse-transcriptase polymerase chain reaction. J Immunol 1994; 153:4427-4435.
53. Vigano P, Gaffuri B, Somigliana E, Infantino M, Vignali M, Di Blasio AM. Interleukin-10 is produced by human uterine natural killer cells but does not affect their production of interferon-gamma. Mol Hum Reprod 2001; 7:971-977.
54. Laird SM, Tuckerman EM, Cork BA, Linjawi S, Blakemore AI, Li TC. A review of immune cells and molecules in women with recurrent miscarriage. Hum Reprod Update 2003; 9:163-174.
55. Singh U, Nicholson G, Urban BC, Sargent IL, Kishore U, Bemal AL. Immunological properties of human decidual macrophages: a possible role in intrauterine immunity. Reproduction 2005; 129:631-637.
56. Agerberth B, Charo J, Werr J, Olsson B, Idali F, Lindbom L, Kiessling R, Jomvall H, Wigzell H, Gudmundsson GH. The human antimicrobial and chemotactic peptides LL-37 and α-defensins are expressed by specific lymphocyte and monocyte populations. Blood 2000; 96:3086-3093.
57. 3 is a direct inducer of antimicrobial peptide gene expression. J Immunol 2004; 173:2909-2912.